newsfilter
← Latest News
PR Newswire·

VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the release of a new clinical study...